Leading Drugs For Psychosis Come Under New Scrutiny

May, 2003 article in the New York Times questioning the promise of second-generation antipsychotics.
Go to New York Times                                              Discuss →

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

LEAVE A REPLY